Safeguard Scientifics, Inc. (SFE)
Stock Price Chart
Key Info
| Market Cap | 128.64M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -29.11M |
| Shares Out | 20.67M |
| EPS (ttm) | -1.41 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Aug 14, 2020 |
| Last Price | $6.19 |
| Previous Close | $6.14 |
| Change ($) | 0.05 |
| Change (%) | 0.81% |
| Day's Open | 6.06 |
| Day's Range | 6.06 - 6.22 |
| Day's Volume | 46,813 |
| 52-Week Range | 4.43 - 12.79 |
More Stats
| Market Cap | 128.64M |
| Enterprise Value | 117.23M |
| Earnings Date (est) | Oct 22, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 20.67M |
| Float | 19.68M |
| EPS (basic) | -1.41 |
| EPS (diluted) | -1.41 |
| FCF / Share | -0.66 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 519,830 |
| Short Ratio | 7.81 |
| Short % of Float | 2.68% |
| Beta | 1.33 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.73 |
| Revenue | n/a |
| Operating Income | -9.88M |
| Net Income | -29.11M |
| Free Cash Flow | -13.56M |
| Net Cash | 11.41M |
| Net Cash / Share | 0.55 |
| Gross Margin | n/a |
| Operating Margin | n/a |
| Profit Margin | n/a |
| FCF Margin | n/a |
| ROA | -3.68% |
| ROE | -29.18% |
| ROIC | n/a |
Analyst Summary
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Operating Income | -9.98 | -16.87 | -17.13 | -18.69 | -17.55 | -18.97 | -21.64 | -19.47 | -21.17 | -20.85 |
| Net Income | 54.56 | -15.63 | -88.57 | -22.26 | -59.52 | -5.15 | -35.53 | -39.36 | 111 | 26.61 |
| Shares Outstanding | 20.64 | 20.54 | 20.43 | 20.34 | 20.87 | 20.98 | 21.36 | 20.97 | 20.76 | 20.54 |
| Earnings Per Share | 2.64 | -0.76 | -4.34 | -1.09 | -2.85 | -0.25 | -1.66 | -1.88 | 4.74 | 1.24 |
| EPS Growth | - | - | - | - | - | - | - | - | 282.26% | - |
| Dividend Per Share | 1.00 | - | - | - | - | - | - | - | - | - |
| Operating Cash Flow | -19.97 | -26.04 | -20.81 | -18.66 | -17.75 | -20.19 | -21.22 | -16.53 | -17.73 | -16.02 |
| Capital Expenditures | - | - | - | -0.43 | -1.86 | -0.06 | -0.04 | -0.07 | -0.06 | -0.11 |
| Free Cash Flow | -19.97 | -26.03 | -20.81 | -19.09 | -19.61 | -20.25 | -21.26 | -16.60 | -17.79 | -16.13 |
| Cash & Equivalents | 25.05 | 46.16 | 28.96 | 30.44 | 63.86 | 137 | 178 | 183 | 253 | 237 |
| Total Debt | 2.38 | 70.17 | 85.81 | 52.56 | 50.96 | 50.56 | 49.95 | 48.99 | 45.69 | 75.92 |
| Net Cash / Debt | 22.67 | -24.02 | -56.84 | -22.12 | 12.90 | 86.60 | 128 | 134 | 207 | 161 |
| Assets | 108 | 146 | 176 | 232 | 257 | 318 | 346 | 374 | 407 | 337 |
| Liabilities | 5.84 | 78.76 | 94.67 | 62.05 | 61.34 | 60.63 | 61.34 | 60.17 | 58.36 | 90.11 |
| Book Value | 102 | 66.98 | 81.80 | 170 | 196 | 258 | 285 | 314 | 348 | 246 |
Company Profile
Company Details
| Full Name | Safeguard Scientifics, Inc. |
| Country | United States |
| CEO | Robert J. Rosenthal |
Stock Information
| Ticker Symbol | SFE |
| Stock Exchange | New York Stock Exchange |
| Sector | Financial Services |
| Industry | Asset Management |
| Unique Identifier | NYSE: SFE |
Description
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Sa